by Stem Cell Network | Nov 2, 2010
Although the use of umbilical cord blood for different medical treatments has been around since 1988, when the first transplant of cord blood was used to treat a patient with Fanconi’s anemia, it’s still a relatively new development in the area of regenerative...
by Stem Cell Network | Oct 22, 2010
In recent years the Stem Cell Network has worked closely with its international colleagues to shed light on clinics offering “stem cell” therapies for which there is scant scientific evidence. One such initiative is A Closer Look at Stem Cell Treatments, a web...
by Allison Van Winkle | Oct 8, 2010
High-throughput screening, in which many cell culture conditions can be tested using a combination of robotics, control software, and/or highly sensitive detection, allows researchers to explore new ideas quickly; thousands of combinations can be efficiently tested...
by Katie Moisse | Oct 6, 2010
Day two of the World Stem Cell Summit featured a much-anticipated update on a groundbreaking clinical trial launched in January to assess the safety and feasibility of injecting fetal stem cells into the spinal cords of people with Amyotrophic Lateral Sclerosis (ALS)....
by David Kent | Sep 30, 2010
Last week, a major kerfuffle erupted in the UK stem cell community as leading scientists and pro stem cell organizations argued that Britain’s range of economic austerity measures would jeopardize their ability to be a major player in translational research. Articles...
by Paul Krzyzanowski | Sep 28, 2010
In the RNA world hypothesis, RNA based biological life can exist without the need for DNA and proteins to store information, make decisions, and in general, control cells. In 1998, the discovery that small RNAs can play important roles in controlling cells...
Comments